Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
Study NCT ID:
NCT01611259
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2012-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-18
First Submit QC Date:
None
Study First Post Date:
2012-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-21
Results First Submit QC Date:
None
Results First Post Date:
2017-11-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-19
Last Update Post Date:
2017-11-06
Last Update Post Date Type:
ACTUAL